Royalty Pharma plc

NasdaqGS:RPRX

Sector

🏥 Health Care

Industries

🧬 Biotechnology

💰 Investment Banking & Asset Management

💊 Pharmaceuticals

💼 Private Equity

💰 Venture Capital

Location

United States

Market Cap

USD 20.91 B

Share Price

USD 35.86

Avg Daily Volume

4,253,556

Change (1 day)

-0.91%

Change (1 year)

35.63%

Change (YTD)

40.57%

Royalty Pharma plc Return on Assets (ROA) for the Trailing 12 Months (TTM) ending August 13, 2025: N/A

Royalty Pharma plc Return on Assets (ROA) is NA for the Trailing 12 Months (TTM) ending August 13, 2025. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Competitors

Investor AB (publ)

USD 30.06

INVE-B.ST

+0.34 1.13%

SBI Holdings, Inc.

USD 44.26

8473.T

-0.02 -0.05%

BB Biotech AG

USD 38.65

BION.SW

+0.20 0.51%

Eli Lilly and Company

USD 639.43

LLY

+4.21 0.66%

AbbVie Inc.

USD 198.64

ABBV

-0.06 -0.03%

Roche Holding AG

USD 320.12

RO.SW

+2.62 0.83%

AstraZeneca PLC

USD 150.15

AZN.L

-2.01 -1.32%

Abbott Laboratories

USD 131.02

ABT

-0.34 -0.26%

Novartis AG

USD 119.03

NOVN.SW

+1.05 0.89%

Novo Nordisk A/S

USD 50.00

NOVO-B.CO

-0.09 -0.18%

Merck & Co., Inc.

USD 80.30

MRK

+0.27 0.34%

Thermo Fisher Scientific Inc.

USD 477.41

TMO

+15.02 3.25%

Amgen Inc.

USD 284.98

AMGN

-0.11 -0.04%

Gilead Sciences, Inc.

USD 120.02

GILD

-0.45 -0.37%

Pfizer Inc.

USD 24.65

PFE

+0.07 0.29%

View all

Key Data

Date	Return on Assets (ROA)	Revenue Per Share	Free Cash Flow Per Share	Dividend Per Share